The intake of other drugs may, however, be related to exacerbations of IBD symptoms, which are also correlated to levels of CRP, serum albumin, and hemoglobin, so confounding by indication is a pitfall if other drugs than infliximab are included in the analyses. Here, ALB is linked to inflammatory bowel disease.